Your browser doesn't support javascript.
loading
The Expression of IL-21 Is Promoted by MEKK4 in Malignant T Cells and Associated with Increased Progression Risk in Cutaneous T-Cell Lymphoma.
Fredholm, Simon; Litvinov, Ivan V; Mongan, Nigel P; Schiele, Sarah; Willerslev-Olsen, Andreas; Petersen, David Leander; Krejsgaard, Thorbjørn; Sibbesen, Nina; Nastasi, Claudia; Bonefeld, Charlotte M; Persson, Jenny L; Straten, Per Thor; Andersen, Mads Hald; Koralov, Sergei B; Wasik, Mariusz M; Geisler, Carsten; Sasseville, Denis; Woetmann, Anders; Ødum, Niels.
Afiliação
  • Fredholm S; Department of Immunology and Microbiology (ISIM), University of Copenhagen, Copenhagen, Denmark.
  • Litvinov IV; Division of Dermatology, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada.
  • Mongan NP; Faculty of Medicine and Health Sciences School of Veterinary Medicine and Science, School of Medicine, University of Nottingham, Nottingham, UK.
  • Schiele S; Department of Immunology and Microbiology (ISIM), University of Copenhagen, Copenhagen, Denmark.
  • Willerslev-Olsen A; Department of Immunology and Microbiology (ISIM), University of Copenhagen, Copenhagen, Denmark.
  • Petersen DL; Department of Immunology and Microbiology (ISIM), University of Copenhagen, Copenhagen, Denmark.
  • Krejsgaard T; Department of Immunology and Microbiology (ISIM), University of Copenhagen, Copenhagen, Denmark.
  • Sibbesen N; Department of Immunology and Microbiology (ISIM), University of Copenhagen, Copenhagen, Denmark.
  • Nastasi C; Department of Immunology and Microbiology (ISIM), University of Copenhagen, Copenhagen, Denmark.
  • Bonefeld CM; Department of Immunology and Microbiology (ISIM), University of Copenhagen, Copenhagen, Denmark.
  • Persson JL; Clinical Research Center, Lund University, Malmö, Sweden.
  • Straten PT; Department of Immunology and Microbiology (ISIM), University of Copenhagen, Copenhagen, Denmark; Center for Cancer Immune Therapy (CCIT), Department of Hematology, Copenhagen University Hospital, Herlev, Denmark.
  • Andersen MH; Department of Immunology and Microbiology (ISIM), University of Copenhagen, Copenhagen, Denmark; Center for Cancer Immune Therapy (CCIT), Department of Hematology, Copenhagen University Hospital, Herlev, Denmark.
  • Koralov SB; Department of Pathology, New York University School of Medicine, New York, New York, USA.
  • Wasik MM; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, USA.
  • Geisler C; Department of Immunology and Microbiology (ISIM), University of Copenhagen, Copenhagen, Denmark.
  • Sasseville D; Division of Dermatology, McGill University Health Center, Montréal, Quebec, Canada.
  • Woetmann A; Department of Immunology and Microbiology (ISIM), University of Copenhagen, Copenhagen, Denmark.
  • Ødum N; Department of Immunology and Microbiology (ISIM), University of Copenhagen, Copenhagen, Denmark. Electronic address: ndum@sund.ku.dk.
J Invest Dermatol ; 136(4): 866-869, 2016 Apr.
Article em En | MEDLINE | ID: mdl-26802931

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Linfócitos T / Regulação Neoplásica da Expressão Gênica / Linfoma de Células T / Interleucinas / MAP Quinase Quinase Quinase 4 Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Invest Dermatol Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Dinamarca País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Linfócitos T / Regulação Neoplásica da Expressão Gênica / Linfoma de Células T / Interleucinas / MAP Quinase Quinase Quinase 4 Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Invest Dermatol Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Dinamarca País de publicação: Estados Unidos